JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=495355, encodeId=b17949535511, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投了一篇viewpoint，还在under review。祝好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2475, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=facf81181, createdName=garlic1, createdTime=Sun Apr 28 13:57:00 CST 2013, time=2013-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494939, encodeId=08194949397f, content=第三次像JAMA发起进攻了，但愿好运！上帝保佑我！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 09 10:04:00 CST 2013, time=2013-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487708, encodeId=96ac48e708ca, content=Target, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 03 10:58:00 CST 2012, time=2012-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483793, encodeId=8131483e93ee, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：主要收录大规模临床试验的文章，强调多中心，创新药物，随机对照双盲设计，才有希望。如果不是创新药物，即使是多中心随机对照，也只能投在一些专业领域的顶尖期刊，想上JAMA，Lancet都不容易。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=811, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=JAMA, createdTime=Wed Aug 03 11:02:00 CST 2011, time=2011-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483767, encodeId=77e7483e672a, content=2010年 2009年 2008年 2007年 30.01 28.89 31.71 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=924, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df7e42554, createdName=liaoyisheng, createdTime=Tue Aug 02 15:57:00 CST 2011, time=2011-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469831, encodeId=76f746983176, content=国内一般一年有2-3篇，强调也是“新”！或大宗，随机对照试验的结果。协作单位一起发，会容易一些。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1037, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jama, createdTime=Thu Dec 17 22:27:00 CST 2009, time=2009-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469243, encodeId=2bed46924346, content=《柳叶刀》(The Lancet)、《英国医学杂志》(BMJ)、《美国医学会杂志》(JAMA)和《新英格兰医学杂志》(NEJM),并称为“现代四大综合类医学期刊”。JAMA也称为美国人的杂志，虽然也偶收录中国人的文章，但很少。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=946, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Aug 30 09:40:00 CST 2009, time=2009-08-30, status=1, ipAttribution=)]

2013-04-28 garlic1

审稿速度:2.0 | 投稿命中率:5.0
经验分享：投了一篇viewpoint，还在under review。祝好运!

2475 0

[GetPortalCommentsPageByObjectIdResponse(id=495355, encodeId=b17949535511, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投了一篇viewpoint，还在under review。祝好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2475, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=facf81181, createdName=garlic1, createdTime=Sun Apr 28 13:57:00 CST 2013, time=2013-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494939, encodeId=08194949397f, content=第三次像JAMA发起进攻了，但愿好运！上帝保佑我！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 09 10:04:00 CST 2013, time=2013-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487708, encodeId=96ac48e708ca, content=Target, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 03 10:58:00 CST 2012, time=2012-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483793, encodeId=8131483e93ee, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：主要收录大规模临床试验的文章，强调多中心，创新药物，随机对照双盲设计，才有希望。如果不是创新药物，即使是多中心随机对照，也只能投在一些专业领域的顶尖期刊，想上JAMA，Lancet都不容易。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=811, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=JAMA, createdTime=Wed Aug 03 11:02:00 CST 2011, time=2011-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483767, encodeId=77e7483e672a, content=2010年 2009年 2008年 2007年 30.01 28.89 31.71 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=924, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df7e42554, createdName=liaoyisheng, createdTime=Tue Aug 02 15:57:00 CST 2011, time=2011-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469831, encodeId=76f746983176, content=国内一般一年有2-3篇，强调也是“新”！或大宗，随机对照试验的结果。协作单位一起发，会容易一些。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1037, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jama, createdTime=Thu Dec 17 22:27:00 CST 2009, time=2009-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469243, encodeId=2bed46924346, content=《柳叶刀》(The Lancet)、《英国医学杂志》(BMJ)、《美国医学会杂志》(JAMA)和《新英格兰医学杂志》(NEJM),并称为“现代四大综合类医学期刊”。JAMA也称为美国人的杂志，虽然也偶收录中国人的文章，但很少。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=946, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Aug 30 09:40:00 CST 2009, time=2009-08-30, status=1, ipAttribution=)]

2013-04-09 匿名用户

第三次像JAMA发起进攻了，但愿好运！上帝保佑我！

2386 0

[GetPortalCommentsPageByObjectIdResponse(id=495355, encodeId=b17949535511, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投了一篇viewpoint，还在under review。祝好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2475, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=facf81181, createdName=garlic1, createdTime=Sun Apr 28 13:57:00 CST 2013, time=2013-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494939, encodeId=08194949397f, content=第三次像JAMA发起进攻了，但愿好运！上帝保佑我！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 09 10:04:00 CST 2013, time=2013-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487708, encodeId=96ac48e708ca, content=Target, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 03 10:58:00 CST 2012, time=2012-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483793, encodeId=8131483e93ee, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：主要收录大规模临床试验的文章，强调多中心，创新药物，随机对照双盲设计，才有希望。如果不是创新药物，即使是多中心随机对照，也只能投在一些专业领域的顶尖期刊，想上JAMA，Lancet都不容易。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=811, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=JAMA, createdTime=Wed Aug 03 11:02:00 CST 2011, time=2011-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483767, encodeId=77e7483e672a, content=2010年 2009年 2008年 2007年 30.01 28.89 31.71 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=924, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df7e42554, createdName=liaoyisheng, createdTime=Tue Aug 02 15:57:00 CST 2011, time=2011-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469831, encodeId=76f746983176, content=国内一般一年有2-3篇，强调也是“新”！或大宗，随机对照试验的结果。协作单位一起发，会容易一些。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1037, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jama, createdTime=Thu Dec 17 22:27:00 CST 2009, time=2009-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469243, encodeId=2bed46924346, content=《柳叶刀》(The Lancet)、《英国医学杂志》(BMJ)、《美国医学会杂志》(JAMA)和《新英格兰医学杂志》(NEJM),并称为“现代四大综合类医学期刊”。JAMA也称为美国人的杂志，虽然也偶收录中国人的文章，但很少。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=946, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Aug 30 09:40:00 CST 2009, time=2009-08-30, status=1, ipAttribution=)]

2012-04-03 匿名用户

Target

2366 0

[GetPortalCommentsPageByObjectIdResponse(id=495355, encodeId=b17949535511, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投了一篇viewpoint，还在under review。祝好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2475, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=facf81181, createdName=garlic1, createdTime=Sun Apr 28 13:57:00 CST 2013, time=2013-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494939, encodeId=08194949397f, content=第三次像JAMA发起进攻了，但愿好运！上帝保佑我！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 09 10:04:00 CST 2013, time=2013-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487708, encodeId=96ac48e708ca, content=Target, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 03 10:58:00 CST 2012, time=2012-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483793, encodeId=8131483e93ee, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：主要收录大规模临床试验的文章，强调多中心，创新药物，随机对照双盲设计，才有希望。如果不是创新药物，即使是多中心随机对照，也只能投在一些专业领域的顶尖期刊，想上JAMA，Lancet都不容易。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=811, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=JAMA, createdTime=Wed Aug 03 11:02:00 CST 2011, time=2011-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483767, encodeId=77e7483e672a, content=2010年 2009年 2008年 2007年 30.01 28.89 31.71 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=924, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df7e42554, createdName=liaoyisheng, createdTime=Tue Aug 02 15:57:00 CST 2011, time=2011-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469831, encodeId=76f746983176, content=国内一般一年有2-3篇，强调也是“新”！或大宗，随机对照试验的结果。协作单位一起发，会容易一些。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1037, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jama, createdTime=Thu Dec 17 22:27:00 CST 2009, time=2009-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469243, encodeId=2bed46924346, content=《柳叶刀》(The Lancet)、《英国医学杂志》(BMJ)、《美国医学会杂志》(JAMA)和《新英格兰医学杂志》(NEJM),并称为“现代四大综合类医学期刊”。JAMA也称为美国人的杂志，虽然也偶收录中国人的文章，但很少。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=946, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Aug 30 09:40:00 CST 2009, time=2009-08-30, status=1, ipAttribution=)]

2011-08-03 JAMA

审稿速度:2.0 | 投稿命中率:5.0
经验分享：主要收录大规模临床试验的文章，强调多中心，创新药物，随机对照双盲设计，才有希望。如果不是创新药物，即使是多中心随机对照，也只能投在一些专业领域的顶尖期刊，想上JAMA，Lancet都不容易。

811 0

[GetPortalCommentsPageByObjectIdResponse(id=495355, encodeId=b17949535511, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投了一篇viewpoint，还在under review。祝好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2475, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=facf81181, createdName=garlic1, createdTime=Sun Apr 28 13:57:00 CST 2013, time=2013-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494939, encodeId=08194949397f, content=第三次像JAMA发起进攻了，但愿好运！上帝保佑我！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 09 10:04:00 CST 2013, time=2013-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487708, encodeId=96ac48e708ca, content=Target, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 03 10:58:00 CST 2012, time=2012-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483793, encodeId=8131483e93ee, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：主要收录大规模临床试验的文章，强调多中心，创新药物，随机对照双盲设计，才有希望。如果不是创新药物，即使是多中心随机对照，也只能投在一些专业领域的顶尖期刊，想上JAMA，Lancet都不容易。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=811, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=JAMA, createdTime=Wed Aug 03 11:02:00 CST 2011, time=2011-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483767, encodeId=77e7483e672a, content=2010年 2009年 2008年 2007年 30.01 28.89 31.71 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=924, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df7e42554, createdName=liaoyisheng, createdTime=Tue Aug 02 15:57:00 CST 2011, time=2011-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469831, encodeId=76f746983176, content=国内一般一年有2-3篇，强调也是“新”！或大宗，随机对照试验的结果。协作单位一起发，会容易一些。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1037, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jama, createdTime=Thu Dec 17 22:27:00 CST 2009, time=2009-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469243, encodeId=2bed46924346, content=《柳叶刀》(The Lancet)、《英国医学杂志》(BMJ)、《美国医学会杂志》(JAMA)和《新英格兰医学杂志》(NEJM),并称为“现代四大综合类医学期刊”。JAMA也称为美国人的杂志，虽然也偶收录中国人的文章，但很少。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=946, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Aug 30 09:40:00 CST 2009, time=2009-08-30, status=1, ipAttribution=)]

2011-08-02 liaoyisheng

2010年 2009年 2008年 2007年
30.01 28.89 31.71

924 0

[GetPortalCommentsPageByObjectIdResponse(id=495355, encodeId=b17949535511, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投了一篇viewpoint，还在under review。祝好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2475, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=facf81181, createdName=garlic1, createdTime=Sun Apr 28 13:57:00 CST 2013, time=2013-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494939, encodeId=08194949397f, content=第三次像JAMA发起进攻了，但愿好运！上帝保佑我！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 09 10:04:00 CST 2013, time=2013-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487708, encodeId=96ac48e708ca, content=Target, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 03 10:58:00 CST 2012, time=2012-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483793, encodeId=8131483e93ee, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：主要收录大规模临床试验的文章，强调多中心，创新药物，随机对照双盲设计，才有希望。如果不是创新药物，即使是多中心随机对照，也只能投在一些专业领域的顶尖期刊，想上JAMA，Lancet都不容易。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=811, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=JAMA, createdTime=Wed Aug 03 11:02:00 CST 2011, time=2011-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483767, encodeId=77e7483e672a, content=2010年 2009年 2008年 2007年 30.01 28.89 31.71 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=924, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df7e42554, createdName=liaoyisheng, createdTime=Tue Aug 02 15:57:00 CST 2011, time=2011-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469831, encodeId=76f746983176, content=国内一般一年有2-3篇，强调也是“新”！或大宗，随机对照试验的结果。协作单位一起发，会容易一些。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1037, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jama, createdTime=Thu Dec 17 22:27:00 CST 2009, time=2009-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469243, encodeId=2bed46924346, content=《柳叶刀》(The Lancet)、《英国医学杂志》(BMJ)、《美国医学会杂志》(JAMA)和《新英格兰医学杂志》(NEJM),并称为“现代四大综合类医学期刊”。JAMA也称为美国人的杂志，虽然也偶收录中国人的文章，但很少。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=946, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Aug 30 09:40:00 CST 2009, time=2009-08-30, status=1, ipAttribution=)]

2009-12-17 jama

国内一般一年有2-3篇，强调也是“新”！或大宗，随机对照试验的结果。协作单位一起发，会容易一些。

1037 0

[GetPortalCommentsPageByObjectIdResponse(id=495355, encodeId=b17949535511, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投了一篇viewpoint，还在under review。祝好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2475, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=facf81181, createdName=garlic1, createdTime=Sun Apr 28 13:57:00 CST 2013, time=2013-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494939, encodeId=08194949397f, content=第三次像JAMA发起进攻了，但愿好运！上帝保佑我！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 09 10:04:00 CST 2013, time=2013-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487708, encodeId=96ac48e708ca, content=Target, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 03 10:58:00 CST 2012, time=2012-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483793, encodeId=8131483e93ee, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：主要收录大规模临床试验的文章，强调多中心，创新药物，随机对照双盲设计，才有希望。如果不是创新药物，即使是多中心随机对照，也只能投在一些专业领域的顶尖期刊，想上JAMA，Lancet都不容易。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=811, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=JAMA, createdTime=Wed Aug 03 11:02:00 CST 2011, time=2011-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483767, encodeId=77e7483e672a, content=2010年 2009年 2008年 2007年 30.01 28.89 31.71 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=924, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df7e42554, createdName=liaoyisheng, createdTime=Tue Aug 02 15:57:00 CST 2011, time=2011-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469831, encodeId=76f746983176, content=国内一般一年有2-3篇，强调也是“新”！或大宗，随机对照试验的结果。协作单位一起发，会容易一些。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1037, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jama, createdTime=Thu Dec 17 22:27:00 CST 2009, time=2009-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469243, encodeId=2bed46924346, content=《柳叶刀》(The Lancet)、《英国医学杂志》(BMJ)、《美国医学会杂志》(JAMA)和《新英格兰医学杂志》(NEJM),并称为“现代四大综合类医学期刊”。JAMA也称为美国人的杂志，虽然也偶收录中国人的文章，但很少。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=946, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Aug 30 09:40:00 CST 2009, time=2009-08-30, status=1, ipAttribution=)]

2009-08-30 匿名用户

《柳叶刀》(The Lancet)、《英国医学杂志》(BMJ)、《美国医学会杂志》(JAMA)和《新英格兰医学杂志》(NEJM),并称为“现代四大综合类医学期刊”。JAMA也称为美国人的杂志，虽然也偶收录中国人的文章，但很少。

946 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务